In the News

1856 News Items found
Headshot of Carol Gemignani
MSK patients that need urgent care may receive care closer to home. That’s when MSK's 34 Shared Care nurses — led by Carol Gemignani — step in.
Barb (right) and Tara huddled close together and wearing masks for a photo
Barbara (“Barb”) Pemberton has a huge smile, an infectious laugh, and a great memory – she vividly remembers how scared she felt when she interviewed t...
MSK computational oncologist Benjamin Greenbaum and cancer immunologist Taha Merghoub.
Mutations that drive cancer growth also make a cell more noticeable to the immune system.
Nurses from the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
Meet the winners of the 2022 Robbins Family Awards for Excellence at Memorial Sloan Kettering Cancer Center.
Hoda Kotb shoots a special reunion at MSK for Nurses Week
To celebrate National Nurses Week (May 6 to May 12), Today Show anchor Hoda Kotb interviewed MSK Nurse Cassie DeMatteis about an extraordinary relationship with one of her littlest patients.
Headshot of Ruthy Gordon, who is director of Clinical Trials Nursing at MSK.
For RuthAnn (“Ruthy”) Gordon, Director of Clinical Trials Nursing, some of the best days are when the FDA approves a drug from a clinical trial that she worked on. It’s happened to her four times.
person with insomnia
Learn about how cognitive behavioral therapy for insomnia (CBT-I) helps people with cancer improve sleep.
Luis A. Diaz, MD
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science.
Headshot of Vik Gill, an analyst for MSK's Institutional Review Board
Vik Gill: The Uplifter
Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants.
A man and a woman sit on a boat wearing life jackets and holding a large icicle. An iceberg sticking out of the water is behind them.
In April 2022, the FDA approved the immunotherapy drug axicabtagene ciloleucel (Yescarta®) for the treatment of diffuse large B cell lymphoma earlier in the course of disease. Retired teacher and basketball coach Joe Crimi is one of the patients who benefited from this treatment.